Literature DB >> 16789344

Additive effects of moderate drinking and obesity on serum gamma-glutamyl transferase activity.

Katri Puukka1, Johanna Hietala, Heidi Koivisto, Petra Anttila, Risto Bloigu, Onni Niemelä.   

Abstract

BACKGROUND: Gamma-glutamyl transferase (GGT) is a widely used index of liver induction and a marker of alcohol overconsumption. Obesity has also been suggested to elevate serum GGT activities.
OBJECTIVE: The aim was to examine the links between moderate ethanol consumption, obesity, and GGT activities.
DESIGN: GGT values were recorded from 2490 persons (1184 men and 1306 women) who reported either no alcohol use (abstainers) or 1-40 g ethanol consumption per day (moderate drinkers). The study population was additionally classified according to body mass index (BMI; in kg/m2) as follows: < 19 (underweight), > or = 19 and < 25 (normal weight), > or = 25 and < 30 (overweight), and 30 (obese).
RESULTS: Significant main effects of sex (P < 0.0001), drinking habits (P < 0.01), and BMI (P < 0.001) on serum GGT activities were observed. The values were higher in the men than in the women and higher in those with higher BMIs. The highest activities were found to occur in persons with moderate drinking combined with overweight or obesity. A significant positive correlation between GGT and BMI (P < 0.0001) was observed, which was stronger for the men (r = 0.24) than for the women (r = 0.15, P < 0.05 for the difference between correlations).
CONCLUSION: The data indicate that serum GGT activities may respond to moderate drinking and overweight in an additive manner; this should be considered in the clinical use of GGT measurements and when defining normal GGT values in health care.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16789344     DOI: 10.1093/ajcn/83.6.1351

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  11 in total

1.  Co-occurrence of obesity and patterns of alcohol use associated with elevated serum hepatic enzymes in US adults.

Authors:  James Tsai; Earl S Ford; Guixiang Zhao; Chaoyang Li; Kurt J Greenlund; Janet B Croft
Journal:  J Behav Med       Date:  2011-05-28

2.  Alcohol, metabolic risk and elevated serum gamma-glutamyl transferase (GGT) in Indigenous Australians.

Authors:  Matthew T Haren; Ming Li; John Petkov; Robyn A McDermott
Journal:  BMC Public Health       Date:  2010-08-03       Impact factor: 3.295

Review 3.  Diagnostic challenges in alcohol use disorder and alcoholic liver disease.

Authors:  Luisa Vonghia; Peter Michielsen; Geert Dom; Sven Francque
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

Review 4.  Diagnosis of alcoholic liver disease.

Authors:  Cara Torruellas; Samuel W French; Valentina Medici
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

5.  KASL clinical practice guidelines: management of alcoholic liver disease.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2013-09-30

Review 6.  Methodology to assess clinical liver safety data.

Authors:  Michael Merz; Kwan R Lee; Gerd A Kullak-Ublick; Andreas Brueckner; Paul B Watkins
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

7.  Gender-specific pathway differences in the human serum metabolome.

Authors:  Jan Krumsiek; Kirstin Mittelstrass; Kieu Trinh Do; Ferdinand Stückler; Janina Ried; Jerzy Adamski; Annette Peters; Thomas Illig; Florian Kronenberg; Nele Friedrich; Matthias Nauck; Maik Pietzner; Dennis O Mook-Kanamori; Karsten Suhre; Christian Gieger; Harald Grallert; Fabian J Theis; Gabi Kastenmüller
Journal:  Metabolomics       Date:  2015-08-04       Impact factor: 4.290

8.  Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease: A Mendelian Randomization Study.

Authors:  Alice R Carter; Maria-Carolina Borges; Marianne Benn; Anne Tybjærg-Hansen; George Davey Smith; Børge G Nordestgaard; Debbie A Lawlor
Journal:  JAMA Netw Open       Date:  2019-03-01

9.  Independent and supra-additive effects of alcohol consumption, cigarette smoking, and metabolic syndrome on the elevation of serum liver enzyme levels.

Authors:  Eun Young Park; Min Kyung Lim; Jin-Kyoung Oh; Heeyoun Cho; Mi Jin Bae; E Hwa Yun; Dong-il Kim; Hai-Rim Shin
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

Review 10.  Biomarker-Based Approaches for Assessing Alcohol Use Disorders.

Authors:  Onni Niemelä
Journal:  Int J Environ Res Public Health       Date:  2016-01-27       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.